FARALLON CAPITAL MANAGEMENT, L.L.C.: 13F holdings
CIK 9096612026Q2
| Positions | 89 |
|---|---|
| Reported value | $21.7bn |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| RVMD REVOLUTION MEDICINES INC | 13,550,796 | $2.5bn | 11.7% |
| EA ELECTRONIC ARTS INC | 7,919,500 | $1.6bn | 7.5% |
| BBIO BRIDGEBIO PHARMA INC | 10,743,063 | $800.1m | 3.7% |
| PTGX PROTAGONIST THERAPEUTICS INC | 6,348,906 | $778.2m | 3.6% |
| EXEL EXELIXIS INC | 13,468,010 | $732.8m | 3.4% |
| LIQUIDIA CORPORATION | 8,365,038 | $666.9m | 3.1% |
| AMZN AMAZON COM INC | 2,632,994 | $627.5m | 2.9% |
| LNTH LANTHEUS HLDGS INC | 5,583,479 | $619.4m | 2.9% |
| NTRA NATERA INC | 2,218,366 | $602.2m | 2.8% |
| UNH UNITEDHEALTH GROUP INC | 1,270,532 | $528.1m | 2.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="909661")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.